BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DataCutoff//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DataCutoff · $AXSM readouts
X-WR-CALDESC:Clinical-trial primary completion dates from ClinicalTrials.go
 v\, refreshed nightly by DataCutoff. Not investment advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06413433-pcd@datacutoff.com
DTSTAMP:20261118T192902Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:~ENGAGE readout (P3) · Axsome Therapeutics\, Inc. $AXSM
DESCRIPTION:Elucidating TAAR-1\, Dopamine\, and Norepinephrine in Binge Eat
 ing Disorder Using Solriamfetol\n\nPrimary completion date: 2026-12 (estim
 ated) — month only\, shown on the 1st\nOriginally planned: 2025-12 (+12.
 0 months)\nPhase 3 · Neuro · Binge-Eating Disorder\nEnrollment: 450 · S
 ites: 45\n\nPrimary completion = last participant's primary-endpoint data 
 collected\; topline results usually follow weeks to months later. Sponsor-
 reported\, often an estimate. Not investment advice.\n\nhttps://datacutoff
 .com/radar.html?nct=NCT06413433\nhttps://clinicaltrials.gov/study/NCT06413
 433
URL:https://datacutoff.com/radar.html?nct=NCT06413433
CATEGORIES:Neuro,Phase 3
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06568367-pcd@datacutoff.com
DTSTAMP:20261118T192902Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:~Solriamfetol 150 mg readout (P3) · Axsome Therapeutics\, Inc. $AX
 SM
DESCRIPTION:Studying Solriamfetol Modulation of TAAR-1\, Dopamine\, and Nor
 epinephrine in Shift Work Disorder (SUSTAIN)\n\nPrimary completion date: 2
 026-12 (estimated) — month only\, shown on the 1st\nPhase 3 · Neuro · 
 Excessive Sleepiness\, Shift-work Disorder\nEnrollment: 520 · Sites: 49\n
 \nPrimary completion = last participant's primary-endpoint data collected\
 ; topline results usually follow weeks to months later. Sponsor-reported\,
  often an estimate. Not investment advice.\n\nhttps://datacutoff.com/radar
 .html?nct=NCT06568367\nhttps://clinicaltrials.gov/study/NCT06568367
URL:https://datacutoff.com/radar.html?nct=NCT06568367
CATEGORIES:Neuro,Phase 3
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
